Skip to main content

Table 1 Participant demographics

From: Muscle synergies demonstrate only minimal changes after treatment in cerebral palsy

Treatment N GMFCS Age Gender Height Mass
   I/II/III y + mo F:M meters kg
BTA 52 18/19/15 6 + 10
(2 + 11)
19:33 1.15
(0.16)
21.3
(8.7)
SDR 38 11/23/4 9 + 4
(2 + 0)
20:18 1.33
(0.10)
29.7
(6.2)
SEMLS 57 20/17/20 12 + 2
(3 + 1)
23:34 1.45
(0.16)
39.3
(14.8)
TD 31 9 + 3
(2 + 9)
17:14 1.38
(0.17)
33.8
(13.3)
  1. NOTE. Values are average (1 SD) or as otherwise indicated
  2. N Number of Participants, GMFCS Gross Motor Function Classification System, y + mo Years + Months, F Female, M Male, BTA Botulinum Toxin Type-A Injection,
  3. SDR Selective Dorsal Rhizotomy, SEMLS Single Event Multi-Level Orthopaedic Surgery, TD Typically-Developing Children